West Pharmaceutical Services Income from Continuous Operations 2010-2024 | WST

West Pharmaceutical Services annual/quarterly income from continuous operations history and growth rate from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
  • West Pharmaceutical Services income from continuous operations for the quarter ending September 30, 2024 was $0.136B, a 15.69% decline year-over-year.
  • West Pharmaceutical Services income from continuous operations for the twelve months ending September 30, 2024 was $0.500B, a 10.69% decline year-over-year.
  • West Pharmaceutical Services annual income from continuous operations for 2023 was $0.593B, a 1.28% increase from 2022.
  • West Pharmaceutical Services annual income from continuous operations for 2022 was $0.586B, a 11.47% decline from 2021.
  • West Pharmaceutical Services annual income from continuous operations for 2021 was $0.662B, a 91.16% increase from 2020.
West Pharmaceutical Services Annual Income from Continuous Operations
(Millions of US $)
2023 $593
2022 $586
2021 $662
2020 $346
2019 $242
2018 $207
2017 $151
2016 $144
2015 $96
2014 $127
2013 $112
2012 $81
2011 $76
2010 $65
2009 $73
West Pharmaceutical Services Quarterly Income from Continuous Operations
(Millions of US $)
2024-09-30 $136
2024-06-30 $111
2024-03-31 $115
2023-12-31 $137
2023-09-30 $161
2023-06-30 $155
2023-03-31 $140
2022-12-31 $103
2022-09-30 $121
2022-06-30 $189
2022-03-31 $174
2021-12-31 $148
2021-09-30 $176
2021-06-30 $187
2021-03-31 $151
2020-12-31 $98
2020-09-30 $82
2020-06-30 $91
2020-03-31 $74
2019-12-31 $64
2019-09-30 $56
2019-06-30 $66
2019-03-31 $55
2018-12-31 $52
2018-09-30 $55
2018-06-30 $56
2018-03-31 $44
2017-12-31
2017-09-30 $51
2017-06-30 $39
2017-03-31 $61
2016-12-31 $39
2016-09-30 $38
2016-06-30 $45
2016-03-31 $22
2015-12-31 $33
2015-09-30 $2
2015-06-30 $28
2015-03-31 $33
2014-12-31 $31
2014-09-30 $31
2014-06-30 $38
2014-03-31 $27
2013-12-31 $24
2013-09-30 $27
2013-06-30 $30
2013-03-31 $32
2012-12-31 $21
2012-09-30 $15
2012-06-30 $16
2012-03-31 $29
2011-12-31 $19
2011-09-30 $17
2011-06-30 $20
2011-03-31 $20
2010-12-31 $6
2010-09-30 $18
2010-06-30 $22
2010-03-31 $20
2009-12-31 $20
2009-09-30 $17
2009-06-30 $20
2009-03-31 $15
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.472B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.492B 21.23
Becton Dickinson (BDX) United States $66.954B 17.60
Cardinal Health (CAH) United States $29.177B 15.82
Cooper (COO) United States $20.662B 29.41
Labcorp (LH) United States $20.273B 16.81
Align Technology (ALGN) United States $16.462B 31.50
Henry Schein (HSIC) United States $8.478B 16.15
Merit Medical Systems (MMSI) United States $5.988B 30.58
DENTSPLY SIRONA (XRAY) United States $3.620B 9.65
CONMED (CNMD) United States $2.268B 18.93
Patterson (PDCO) United States $1.833B 9.67
STAAR Surgical (STAA) United States $1.458B 53.80
Lifevantage (LFVN) United States $0.171B 22.77
Pro-Dex (PDEX) United States $0.139B 27.71